Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

AORTIC working with BGICS for better cancer care in Africa

Prof Abubakar Mohammed Bello - President, AORTIC

AORTIC working with BGICS for better cancer care in Africa ( Prof Abubakar Mohammed Bello - President, AORTIC )

Patient quality of life in adult ALL

Zack Pemberton-Whiteley (UK)

Patient quality of life in adult ALL ( Zack Pemberton-Whiteley (UK) )

CAR-T cell therapy for ALL: Current challenges and future approaches

Dr Sara Ghorashian - University College London, London, UK

CAR-T cell therapy for ALL: Current challenges and future approaches ( Dr Sara Ghorashian - University College London, London, UK )

Considerations for treatment sequencing in B-ALL

Prof Nicola Gökbuget - Universitätsklinikum Frankfurt, Frankfurt, Germany

Considerations for treatment sequencing in B-ALL ( Prof Nicola Gökbuget - Universitätsklinikum Frankfurt, Frankfurt, Germany )

CART-T cell therapy in young patients with relapsed/refractory ALL

Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany

$CART-T cell therapy in young patients with relapsed/refractory ALL ( Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany )$

HSCT: Donor selection for patients with ALL

Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology...

HSCT: Donor selection for patients with ALL ( Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )

Therapy of Ph-positive adult ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, UK

Therapy of Ph-positive adult ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )

The role of blinatumomab followed by HSCT in paediatric patients with ALL

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

The role of blinatumomab followed by HSCT in paediatric patients with ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Defining the role of immunotherapy in B-cell ALL

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

Defining the role of immunotherapy in B-cell ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

Long-term toxicities in paediatric ALL

Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark

Long-term toxicities in paediatric ALL ( Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark )

How is minimal residual disease managed in patients with ALL?

Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy

How is minimal residual disease managed in patients with ALL? ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )

BLAST: Blinatumomab for minimal residual disease in patients with ALL

Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy

BLAST: Blinatumomab for minimal residual disease in patients with ALL ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )

More from ecancer